This announcement is a separate document:
双成药业:董事会对独立董事独立性评估的专项意见
Hainan Shuangcheng Pharmaceuticals: The Board's Special Opinions on Evaluating the Independence of Independent Directors
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.